{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:14:59Z","timestamp":1790198099207,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ccm.2017.07.013","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T02:31:56Z","timestamp":1506652316000},"page":"727-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Respiratory Fungal Infections in Solid Organ and Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"38","author":[{"given":"Oveimar","family":"De La Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda P.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib1","first-page":"269","article-title":"Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH alliance(R) registry analysis","volume":"55","author":"Husain","year":"2017","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.ccm.2017.07.013_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x","article-title":"The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants","volume":"4","author":"Minari","year":"2002","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2017.07.013_bib4","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1080\/13693780400020113","article-title":"Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program","volume":"43","author":"Morgan","year":"2005","journal-title":"Med Mycol"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2017.07.013_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"Aspergillosis in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2017.07.013_bib7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2017.07.013_bib8","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1378\/chest.112.5.1160","article-title":"Aspergillus airway colonization and invasive disease after lung transplantation","volume":"112","author":"Cahill","year":"1997","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ccm.2017.07.013_bib9","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1600-6143.2009.02635.x","article-title":"Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome","volume":"9","author":"Weigt","year":"2009","journal-title":"Am J Transplant"},{"issue":"3 Pt 1","key":"10.1016\/j.ccm.2017.07.013_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1164\/ajrccm\/144.3_Pt_1.552","article-title":"Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis","volume":"144","author":"Kramer","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.07.013_bib11","first-page":"103","article-title":"Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients","volume":"30","author":"Vazquez","year":"2017","journal-title":"Rev Esp Quimioter"},{"issue":"6","key":"10.1016\/j.ccm.2017.07.013_bib12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1148\/radiographics.17.6.9397451","article-title":"Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings","volume":"17","author":"Worthy","year":"1997","journal-title":"Radiographics"},{"issue":"10","key":"10.1016\/j.ccm.2017.07.013_bib13","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.crad.2012.02.017","article-title":"Pulmonary complications in the non-HIV immunocompromised patient","volume":"67","author":"Jepson","year":"2012","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1399-3062.2010.00499.x","article-title":"Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients","volume":"12","author":"Park","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2017.07.013_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients","volume":"18","author":"Singh","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.ccm.2017.07.013_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/510388","article-title":"Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.ccm.2017.07.013_bib19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2017.07.013_bib20","doi-asserted-by":"crossref","first-page":"e43347","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2017.07.013_bib21","unstructured":"Husain S, Akinlolu Y, Chaparro C, et\u00a0al. Utility of BAL galactomannan (GM) and culture based preemptive antifungal therapy (PET) strategy in lung transplant recipients (LTRs). Paper presented at the 52nd Interscience Conference on Antimicrobial Agents Chemotherapy (ICAAC). San Francisco (CA), September 9-12, 2012."},{"issue":"6","key":"10.1016\/j.ccm.2017.07.013_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"10020","key":"10.1016\/j.ccm.2017.07.013_bib23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ccm.2017.07.013_bib25","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ccm.2017.07.013_bib26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2017.07.013_bib28","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-aspergillus mold infections in transplant recipients, United States, 2001-2006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2017.07.013_bib29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"949","key":"10.1016\/j.ccm.2017.07.013_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/pgmj.2003.016030","article-title":"Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes","volume":"80","author":"Bhansali","year":"2004","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.ccm.2017.07.013_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2017.07.013_bib32","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1600-6143.2006.01496.x","article-title":"Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature","volume":"6","author":"Almyroudis","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib33","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ccm.2017.07.013_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00001432-200412000-00003","article-title":"Zygomycosis (mucormycosis): emerging clinical importance and new treatments","volume":"17","author":"Greenberg","year":"2004","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2017.07.013_bib35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2017.07.013_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ccm.2017.07.013_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1399-3062.2006.00149.x","article-title":"Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab","volume":"9","author":"Silveira","year":"2007","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome","volume":"7","author":"Husain","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2017.07.013_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005792-200109000-00004","article-title":"The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center","volume":"80","author":"Vilchez","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ccm.2017.07.013_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2017.07.013_bib42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2017.07.013_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.11510","article-title":"Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection","volume":"98","author":"Nucci","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ccm.2017.07.013_bib44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/cid\/ciu947","article-title":"Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients","volume":"60","author":"Garnica","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2017.07.013_bib45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0035-1562897","article-title":"Fusariosis","volume":"36","author":"Nucci","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2017.07.013_bib46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1469-0691.12409","article-title":"Improvement in the outcome of invasive fusariosis in the last decade","volume":"20","author":"Nucci","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.ccm.2017.07.013_bib47","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/AAC.00636-16","article-title":"Antimold prophylaxis may reduce the risk of invasive fusariosis in hematologic patients with superficial skin lesions with positive culture for Fusarium","volume":"60","author":"Varon","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.ccm.2017.07.013_bib48","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/cid\/cit593","article-title":"Histoplasmosis after solid organ transplant","volume":"57","author":"Assi","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2017.07.013_bib49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/srin.2001.29318","article-title":"Coccidioidomycosis complicating solid organ transplantation","volume":"16","author":"Logan","year":"2001","journal-title":"Semin Respir Infect"},{"issue":"9","key":"10.1016\/j.ccm.2017.07.013_bib51","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/323463","article-title":"Coccidioidomycosis in solid organ transplantation","volume":"33","author":"Blair","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2017.07.013_bib52","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2017.07.013_bib53","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1086\/588300","article-title":"Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America","volume":"46","author":"Chapman","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2017.07.013_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/426445","article-title":"Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome","volume":"40","author":"Husain","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2017.07.013_bib55","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1111\/j.1399-0012.2011.01528.x","article-title":"Ochroconis gallopava: a dematiaceous mold causing infections in transplant recipients","volume":"26","author":"Qureshi","year":"2012","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/srin.2002.36444","article-title":"Infectious pulmonary complications in lung transplant recipients","volume":"17","author":"Chan","year":"2002","journal-title":"Semin Respir Infect"},{"issue":"2","key":"10.1016\/j.ccm.2017.07.013_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/TP.0b013e3181c3c417","article-title":"Impact of mold infections in explanted lungs on outcomes of lung transplantation","volume":"89","author":"Vadnerkar","year":"2010","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.123.3.800","article-title":"Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients","volume":"123","author":"Helmi","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2017.07.013_bib59","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1378\/chest.114.5.1321","article-title":"Pulmonary aspergillosis in cystic fibrosis lung transplant recipients","volume":"114","author":"Nunley","year":"1998","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2017.07.013_bib60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00007890-200101270-00013","article-title":"Hypogammaglobulinemia in lung transplant recipients","volume":"71","author":"Goldfarb","year":"2001","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management","volume":"22","author":"Singh","year":"2003","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib62","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.TP.0000044358.99414.B8","article-title":"The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis","volume":"75","author":"Munoz","year":"2003","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ccm.2017.07.013_bib63","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-6143.2004.00390.x","article-title":"Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis","volume":"4","author":"Munoz","year":"2004","journal-title":"Am J Transplant"},{"issue":"13","key":"10.1016\/j.ccm.2017.07.013_bib64","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ccm.2017.07.013_bib65","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bmt.1704543","article-title":"Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation","volume":"34","author":"Thursky","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1399-3062.2009.00480.x","article-title":"Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation","volume":"12","author":"Leithauser","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2017.07.013_bib67","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.idc.2006.06.003","article-title":"Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management","volume":"20","author":"Kontoyiannis","year":"2006","journal-title":"Infect Dis Clin North Am"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523117300795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523117300795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:56:40Z","timestamp":1759453000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523117300795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0272523117300795"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2017.07.013","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory Fungal Infections in Solid Organ and Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2017.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}